Autoimmune diseases (ADs) are chronic conditions initiated by the loss of immunological tolerance to self-antigens. The pathogenic hypothesis comprises a complex interaction between genetic, environmental and hormonal factors that interact with an individual over time generating a dysregulation of the immune system leading to disease development. Several polymorphic genes contribute to the development of ADs. Furthermore, age and gender play a major role by influencing hormone levels that can represent the fulcrum unbalancing from susceptibility to protection. Evidences suggest that while all these steps occur, the susceptible individual develops autoantibodies over a long time lapse. Such autoantibody production is genetically determined and finally, their presence seems to determine the clinical presentation of ADs. The genetic predisposition to the developments of autoantibodies and toward the disease process may overlap. The unveiling of these mechanisms could allow not only to treat but also to prevent the development of autoimmune diseases. © 2013 Springer Science+Business Media New York.

Genetics and autoantibodies / Perricone, Carlo; Nancy Agmon, Levin; Ceccarelli, Fulvia; Valesini, Guido; Juan Manuel, Anaya; Yehuda, Shoenfeld. - In: IMMUNOLOGIC RESEARCH. - ISSN 0257-277X. - STAMPA. - 56:2-3(2013), pp. 206-219. [10.1007/s12026-013-8396-9]

Genetics and autoantibodies.

PERRICONE, CARLO;CECCARELLI, FULVIA;VALESINI, Guido;
2013

Abstract

Autoimmune diseases (ADs) are chronic conditions initiated by the loss of immunological tolerance to self-antigens. The pathogenic hypothesis comprises a complex interaction between genetic, environmental and hormonal factors that interact with an individual over time generating a dysregulation of the immune system leading to disease development. Several polymorphic genes contribute to the development of ADs. Furthermore, age and gender play a major role by influencing hormone levels that can represent the fulcrum unbalancing from susceptibility to protection. Evidences suggest that while all these steps occur, the susceptible individual develops autoantibodies over a long time lapse. Such autoantibody production is genetically determined and finally, their presence seems to determine the clinical presentation of ADs. The genetic predisposition to the developments of autoantibodies and toward the disease process may overlap. The unveiling of these mechanisms could allow not only to treat but also to prevent the development of autoimmune diseases. © 2013 Springer Science+Business Media New York.
2013
autoantibody; genetic; polymorphisms; systemic lupus erythematosus; saccharomyces cerevisiae; autoimmunity
01 Pubblicazione su rivista::01a Articolo in rivista
Genetics and autoantibodies / Perricone, Carlo; Nancy Agmon, Levin; Ceccarelli, Fulvia; Valesini, Guido; Juan Manuel, Anaya; Yehuda, Shoenfeld. - In: IMMUNOLOGIC RESEARCH. - ISSN 0257-277X. - STAMPA. - 56:2-3(2013), pp. 206-219. [10.1007/s12026-013-8396-9]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/513934
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 23
social impact